Fascination About lenmeldy
The FDA assessed the security and efficiency of atidarsagene autotemcel based upon facts from 37 young children who obtained atidarsagene autotemcel in two one-arm, open-label clinical trials As well as in an expanded accessibility program.[7] Youngsters who received procedure with atidarsagene autotemcel have been when compared with untreated kids